Mild skin irritation (redness, burning sensation) when using high concentrations
(6) Pomfrett CJ, Dolling S, Anders NR, Glover DG, Bryan A, Pollard BJ
But the drugs are being monitored
Verify the current MUE table for CPT 96372 against the April 2026 release before billing multiple units on the same date of service Source: CMS MUE Table GLP-1 Coverage Expansion: Medicare Part B coverage for GLP-1 agents used for obesity management is expanding in 2026
This program removes the need for in-person visits while still maintaining licensed medical oversight throughout the process
Using the peptide calculator ensures accurate dosing, while understanding proper injection techniques is essential for subcutaneous and intramuscular administration